Adaptive Biotechnologies (ADPT) Stock: Buy, Sell, or Hold?
ADPT - Adaptive Biotechnologies Corporation Common Stock
$25.33
0.91 (3.73%)
▲
5d:
-1.13%
30d:
-9.73%
90d:
+13.54%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When ADPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ADPT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ADPT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ADPT is currently trading at $25.33, which is considered slightly low relative to its 30-day fair value range of $25.29 to $28.73.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $23.85, while resistance sits at $26.85. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: ADPT scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $29.81 (+17.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $23.85, while resistance sits at $26.85. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: ADPT scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $29.81 (+17.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$25.29 -
$28.73
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
97.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading below Wall St target ($29.81)
- BULLISH: Bottoming setup score 77/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$25.29 -
$28.73
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.85
Resistance Level
$26.85
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-140.49
Wall Street Target
$29.81
(+17.7%)
Revenue Growth (YoY)
21.5%
Profit Margin
-20.7%
Share & Embed Analysis
Last updated: October 22, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 61 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 42 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 44 HOLD |
Advanced ADPT Option Strategies
Professional options setups generated by AI based on today's ADPT price and gamma walls.
